Lannebo Global Growth increased by 7.2 percent in May, according to reports from Aktiellt. The fund’s performance coincided with the divestment of several key holdings, including positions in Mastercard, Intuit, Progressive, and Boston Scientific, as the fund adjusted its global growth portfolio.
Which assets were removed from the portfolio?
Lannebo Global Growth exited several high-profile positions during the month of May. According to Aktiellt, the fund sold its stakes in the medical technology firm Boston Scientific, the payment network Mastercard, the insurance provider Progressive, and the financial software company Intuit.
Analyzing the 7.2 percent gain
The 7.2 percent rise reflects the fund’s monthly growth. In professional fund management, selling off established growth stocks—such as those in the payments and software sectors—often indicates profit-taking after a period of appreciation or a strategic shift to reallocate capital into different industries.